Category :

Infectious Diseases Press Releases

Dr. Eric Lawitz, of the Texas Liver Institute, Publishes on a New Standard of Care for Patients With Chronic Hepatitis C Infection and Severe Renal Impairment

Dr. Eric Lawitz, internationally recognized for his work in liver disease, published groundbreaking results from a Phase 3 study in patients with chronic hepatitis C infection and severe renal impairment.   The study was performed at the American Research Corp at the Texas…

InDevR Licenses Mount Sinai Influenza Antibodies for VaxArray® Neuraminidase Potency Assay

InDevR Licenses Mount Sinai Influenza Antibodies for VaxArray® Neuraminidase Potency Assay

​​InDevR, a Boulder-based progressive analytical technology and life science instrumentation company today announced that it has entered into an exclusive, world-wide license agreement for monoclonal antibodies developed by scientists at the Icahn School of Medicine at Mount Sinai. The license agreement…

Innovative BioDefense Announces First US Patent on Novel Zylast Technology

Innovative BioDefense, Inc. was granted its first U.S. patent, US 9,717,669 on its Zylast™ products. The patent is on the formula for the Zylast Antiseptic Lotion confirming the novelty and uniqueness of this formulation. The patent describes a “method of dual-action…

diagnostics.ai Win Digital Health 2017 Award for 'Best Data-Driven Innovation'

diagnostics.ai Win Digital Health 2017 Award for 'Best Data-Driven Innovation'

The Digital Health 2017 awards, presented in collaboration with the UK’s Digital Catapult, are awarded based on help to patients and doctors, as well as innovativeness of approach. diagnostics.ai were awarded for their advances in automating precision molecular diagnostics, which…

Study Reveals a New Method to Address a Major Barrier to Eradicating HIV

Study Reveals a New Method to Address a Major Barrier to Eradicating HIV

Scientists at the Gladstone Institutes discovered that an enzyme called SMYD2 could be a new therapeutic target for flushing out the HIV that hides in infected individuals. Overcoming this latent virus remains the most significant obstacle to a cure. While…

Memorial Sloane Kettering Cancer Center Support Means Individuals Will Pay Less to Attend Upcoming Infection-Prevention Conference

Memorial Sloane Kettering Cancer Center Support Means Individuals Will Pay Less to Attend Upcoming Infection-Prevention Conference

​Patient safety education group Pulse Center for Patient Safety Education and Advocacy (formerly PULSE of NY) announces an unbeatable offer on registration for its May 1 Symposium, Infection Prevention: It Begins with You. Private individuals who register early will pay…

Rock-Bottom Discount on May 1 Infection Prevention Event Offered to Members of the Public

Rock-Bottom Discount on May 1 Infection Prevention Event Offered to Members of the Public

Patient safety education group Pulse Center for Patient Safety Education and Advocacy (formerly PULSE of NY) announces an unbeatable offer on tickets for its May 1 Symposium, Infection Prevention: It Begins with You. Private individuals who register early will pay…

bioMONTR Labs to Provide Testing Services for CytoDyn PRO 140 Clinical Trials

bioMONTR Labs to Provide Testing Services for CytoDyn PRO 140 Clinical Trials

bioMONTR Labs announced today they have entered into new Master Service Agreements to provide HIV-1 viral load testing services for CytoDyn’s ongoing Phase 2b PRO 140 Monotherapy Extension Study and their upcoming Phase 3 PRO 140 Monotherapy Study. "We are…

xTAG® Gastrointestinal Pathogen Panel (GPP) Now Available Through Accu Reference Medical Lab

xTAG® Gastrointestinal Pathogen Panel (GPP) Now Available Through Accu Reference Medical Lab

​​​​​​Accu Reference Medical Lab adds a Luminex xTAG® Gastrointestinal Pathogen Panel (GPP) to its lineup of highly sensitive, rapid response diagnostic tests. Diarrhea disease strikes more than two billion times globally each year and is a leading cause of child…

Seattle Biotech SpringStar Awarded Major Research Grant to Combat Zika

Seattle Biotech SpringStar Awarded Major Research Grant to Combat Zika

SpringStar, Inc, a Seattle biotech company, has been awarded another $1.5 million to develop new mosquito control products, this time directed at mosquitoes that transmit Zika and other viruses such as dengue, chikungunya, west Nile virus, and yellow fever. Awarded…

Metagenomics Sequencing Studies Show That the Human Skin Microbial Population Is Highly Stable—CD Genomics

Metagenomics Sequencing Studies Show That the Human Skin Microbial Population Is Highly Stable—CD Genomics

​May 11, 2016, a new study of metagenomics sequencing shows that our personal skin microbial environment remains highly stable despite frequently cleaning and exposing to rich-bacteria objects. This knowledge can be used to better understand a series of human skin…

Introducing: InvisiArmor® Medical Residual Hydrogen Peroxide™ Technology for Textiles

​​dReiniger LLC announces the launch of its first family of infection prevention products for healthcare; the InvisiArmor Medical© Residual Hydrogen Peroxide™ Textile Activator, Application Bottle, and tagging system. This newly patented formulation and application process for textiles is a breakthrough…

South Florida HIV Grant Recipients Report Important Strides in Research Efforts

Thanks to $30,000 fast-track grants awarded by The Campbell Foundation, three South Florida HIV/AIDS research groups have been able to successfully obtain critical state and national funding to further their investigational efforts. The fast-track grants were awarded in July 2015…

3rd Euro-Global Conference on Infectious Diseases

​​​Recommended Infectious Diseases Conferences | Microbiology Conferences | Infection Conferences  International conference tracks description and summury Robert Hensley, Event Manager OMICS International Conferences invites all the participants from all over the world to attend ‘Infectious Diseases Europe 2016’ which includes prompt Keynote Presentations, Special Sessions, Workshops,…

Seattle Biotech Firm, SpringStar, Steps-Up Fight Against Zika and Dengue Fever

Seattle Biotech Firm, SpringStar, Steps-Up Fight Against Zika and Dengue Fever

​SpringStar, Inc, a Seattle biotech company, has stepped up their efforts to fight against mosquitoes that transmit Zika. The company’s Mosquito Trap-N-Kill™, the only EPA-registered trap of its type, targets mosquitoes that spread Zika and dengue fever. The Hawaii Department…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login